Evidence map›Paper›PMID 28824601›Full record

ArticleFrontiers in microbiology2017

Red-Shifted Firefly Luciferase Optimized for

Stephane Dorsaz, Alix T Coste, Dominique Sanglard

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. InvestigatingJournal of fungi (Basel, Switzerland) · 2021
    Article
  10. Article
  11. How to Select Firefly Luciferin Analogues for In Vivo Imaging.International journal of molecular sciences · 2021
    Review
  12. Article
  13. The Added Value of Longitudinal Imaging for PreclinicalAntimicrobial agents and chemotherapy · 2020
    Article
  14. Review
  15. Article
  16. A Bright Future for Fluorescence Imaging of Fungi in Living Hosts.Journal of fungi (Basel, Switzerland) · 2019
    Review
  17. Monitoring of Fluconazole and Caspofungin Activity againstAntimicrobial agents and chemotherapy · 2019
    Article
  18. Protein-Protein Interactions inFrontiers in microbiology · 2019
    Review
  19. Methodologies forMicrobial cell (Graz, Austria) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Stephane DorsazInstitute of Microbiology, University of LausanneLausanne, Switzerland.
Alix T CosteInstitute of Microbiology, University of LausanneLausanne, Switzerland.
Dominique SanglardInstitute of Microbiology, University of LausanneLausanne, Switzerland.
University of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antifungal agentsCandida albicansimaging techniquesluciferasemice

Identifiers

PMID28824601
PMCPMC5541039
OpenAlexW2740441386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.